loading
Schlusskurs vom Vortag:
$14.09
Offen:
$14.11
24-Stunden-Volumen:
460.98K
Relative Volume:
0.41
Marktkapitalisierung:
$11.75B
Einnahmen:
$3.85B
Nettoeinkommen (Verlust:
$667.93M
KGV:
21.42
EPS:
0.657
Netto-Cashflow:
$142.30M
1W Leistung:
+0.66%
1M Leistung:
-1.86%
6M Leistung:
+11.87%
1J Leistung:
-9.39%
1-Tages-Spanne:
Value
$14.04
$14.11
1-Wochen-Bereich:
Value
$13.97
$14.23
52-Wochen-Spanne:
Value
$12.26
$16.17

Dr Reddys Laboratories Ltd Adr Stock (RDY) Company Profile

Name
Firmenname
Dr Reddys Laboratories Ltd Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
27,811
Name
Twitter
@drreddys
Name
Nächster Verdiensttermin
2025-07-23
Name
Neueste SEC-Einreichungen
Name
RDY's Discussions on Twitter

Vergleichen Sie RDY mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
RDY
Dr Reddys Laboratories Ltd Adr
14.07 11.73B 3.85B 667.93M 142.30M 0.657
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
143.41 64.42B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.45 45.95B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
8.81 39.14B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.05 22.90B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
458.13 20.50B 3.08B 1.24B 1.07B 25.61

Dr Reddys Laboratories Ltd Adr Stock (RDY) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-05 Hochstufung HSBC Securities Hold → Buy
2024-12-19 Herabstufung Nomura Buy → Neutral
2024-01-11 Herabstufung Jefferies Buy → Underperform
2023-08-29 Herabstufung HSBC Securities Buy → Hold
2023-05-18 Herabstufung Bernstein Outperform → Mkt Perform
2023-03-17 Hochstufung BofA Securities Neutral → Buy
2023-01-30 Eingeleitet JP Morgan Underweight
2022-11-14 Herabstufung Credit Suisse Neutral → Underperform
2022-01-03 Fortgesetzt BofA Securities Neutral
2021-07-27 Herabstufung Credit Suisse Outperform → Neutral
2021-02-02 Hochstufung Barclays Equal Weight → Overweight
2020-09-18 Hochstufung BofA Securities Neutral → Buy
2020-09-18 Hochstufung Investec Sell → Hold
2020-01-28 Herabstufung CLSA Buy → Outperform
2020-01-27 Herabstufung CLSA Buy → Outperform
2020-01-09 Hochstufung Citigroup Sell → Buy
2019-11-04 Herabstufung BofA/Merrill Buy → Neutral
2019-09-04 Hochstufung Credit Suisse Underperform → Outperform
2019-07-01 Hochstufung Macquarie Neutral → Outperform
2019-06-20 Eingeleitet Deutsche Bank Hold
2019-06-11 Eingeleitet Barclays Equal Weight
2019-05-20 Herabstufung Morgan Stanley Overweight → Equal-Weight
2019-02-19 Hochstufung CLSA Outperform → Buy
2019-01-17 Herabstufung Citigroup Neutral → Sell
2017-09-21 Hochstufung Morgan Stanley Equal-Weight → Overweight
2017-08-31 Hochstufung CLSA Underperform → Outperform
2017-07-28 Herabstufung CLSA Underperform → Sell
2016-07-27 Herabstufung HSBC Securities Hold → Reduce
2016-07-27 Herabstufung Jefferies Hold → Underperform
2016-02-10 Hochstufung Credit Agricole Underperform → Buy
2015-11-10 Herabstufung Citigroup Buy → Neutral
Alle ansehen

Dr Reddys Laboratories Ltd Adr Aktie (RDY) Neueste Nachrichten

pulisher
Oct 03, 2025

Esperion Reaches Settlement Agreement with ANDA Filer, Dr. Reddy’s Laboratories, Not to Market Generic Versions of NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) Prior to April 19, 2040 - GlobeNewswire Inc.

Oct 03, 2025
pulisher
Oct 02, 2025

Asian ADRs Rise As Regional Firms Show Mixed Performance - Finimize

Oct 02, 2025
pulisher
Sep 30, 2025

LLY Stock Quote Price and Forecast - CNN

Sep 30, 2025
pulisher
Sep 26, 2025

Dr Reddys Share Price Update: Company Reports Negative Monthly Returns - Meyka

Sep 26, 2025
pulisher
Sep 24, 2025

GDR, ADR & IDR Companies Stock Prices | IIFL Capital - India Infoline

Sep 24, 2025
pulisher
Sep 24, 2025

NVO Stock Quote Price and Forecast - CNN

Sep 24, 2025
pulisher
Sep 22, 2025

Asian ADRs In The US Start The Week On A High Note - Finimize

Sep 22, 2025
pulisher
Sep 20, 2025

Bizarre Stock Volatility? How Is H1B News Affecting Infosys & Wipro Share Prices On Saturday? - Free Press Journal

Sep 20, 2025
pulisher
Sep 17, 2025

Asian ADR Index Edges Up As LG Display Leads - Finimize

Sep 17, 2025
pulisher
Sep 16, 2025

Dr. Reddy’s Laboratories Allots Equity Shares Under Employee Stock Option Scheme - The Globe and Mail

Sep 16, 2025
pulisher
Sep 15, 2025

Dr Reddy's shares fall as USFDA flags Hyderabad plant with 5 observations - Business Standard

Sep 15, 2025
pulisher
Sep 11, 2025

Asian ADRs Gain As Investors Show Renewed Interest - Finimize

Sep 11, 2025
pulisher
Sep 10, 2025

Asian Equities In The US Logged Broad Gains This Session - Finimize

Sep 10, 2025
pulisher
Sep 03, 2025

Mixed Performance For Asian Stocks Traded In The US - Finimize

Sep 03, 2025
pulisher
Aug 29, 2025

Dr. Reddy’s Laboratories Allots Equity Shares to Employees - TipRanks

Aug 29, 2025
pulisher
Aug 26, 2025

Invesco Ltd. Has $8.12 Million Stake in ATRenew Inc. Sponsored ADR $RERE - Defense World

Aug 26, 2025
pulisher
Aug 25, 2025

Validea's Top Health Care Stocks Based On Peter Lynch8/25/2025 - Nasdaq

Aug 25, 2025
pulisher
Aug 25, 2025

Coya Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) Application for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS) - Barchart.com

Aug 25, 2025
pulisher
Aug 21, 2025

National Bank of Canada FI Boosts Stock Position in Dr. Reddy's Laboratories Ltd $RDY - MarketBeat

Aug 21, 2025
pulisher
Aug 20, 2025

Asian ADRs Trade Lower As S&P Asia 50 Index Drops - Finimize

Aug 20, 2025
pulisher
Aug 18, 2025

Asian Tech Names Lift US-Traded Stocks To A Small Gain - Finimize

Aug 18, 2025
pulisher
Aug 08, 2025

Dr. Reddy’s Subsidiary Imperial Dissolved Following NCLT Approval - TipRanks

Aug 08, 2025
pulisher
Aug 07, 2025

(PDF) ADRs and underlying stock returns: empirical evidence from India - researchgate.net

Aug 07, 2025
pulisher
Aug 06, 2025

Trump Tariff Impact: Infosys, Wipro, HDFC Bank, Other ADR Shares Drop After US Levies 50% Tariff On India - MSN

Aug 06, 2025
pulisher
Aug 06, 2025

Asian Stocks In The US See Mixed Moves Across Sectors - Finimize

Aug 06, 2025
pulisher
Aug 06, 2025

Trump hikes tariffs on India by additional 25% citing Russian oil trade; iShares India ETF, ADRs react - Moneycontrol

Aug 06, 2025
pulisher
Aug 02, 2025

Asian ADRs Fall As Winners And Losers Stand Out - Finimize

Aug 02, 2025
pulisher
Aug 01, 2025

Dr Reddys Laboratories Faces Continued Stock Decline Amid Broader Market Challenges - Markets Mojo

Aug 01, 2025
pulisher
Jul 31, 2025

Asian ADRs Falter On US Markets As Fintechs Slide - Finimize

Jul 31, 2025
pulisher
Jul 31, 2025

Trump’s Tariffs on India highlights: Sensex falls 800 points, Trump launches fresh attack on India for Russia ties - Mint

Jul 31, 2025
pulisher
Jul 30, 2025

Trump Tariff Impact: Infosys, Wipro, HDFC Bank, Other ADR Shares Drop After US Levies 25% Tariff On India - MSN

Jul 30, 2025

Finanzdaten der Dr Reddys Laboratories Ltd Adr-Aktie (RDY)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$10.11
price down icon 0.25%
$57.42
price up icon 4.86%
$20.59
price down icon 0.31%
$136.83
price down icon 1.87%
$458.22
price up icon 1.11%
Kapitalisierung:     |  Volumen (24h):